Skip to content

Welcome to Discover Pharma! Today is : November 12, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Drug Discovery & Development

  • Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development

    CureDuchenne backs Entos in bid to deliver full-length, redosable dystrophin gene therapy

    A new partnership aims to change the game in gene [...]

    May 5, 2026
  • Advanced Therapies,Drug Delivery & Formulation,Drug Discovery & Development,Manufacturing & Supply Chain

    Inside CTMC: Innovating cell therapy development from patient to clinic

    Cell therapy has emerged as one of the most promising [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Opinion & Events

    NICE backs mirikizumab for treatment-resistant Crohn’s disease

    The National Institute for Health and Care Excellence (NICE) has [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    Vivodyne raises $40M to advance human tissue testing as alternative to animal models

    Vivodyne has secured $40 million in Series A funding to [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development

    Why patient-centric trial design is the future of oncology: Q&A with One2Treat’s chief medical officer Pascal Piedbois

    As oncology research continues to evolve, the focus is increasingly [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development

    Ochre Bio appoints pharma veteran Elaine Sullivan as senior independent director

    RNA therapeutics developer Ochre Bio has appointed Dr Elaine Sullivan [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development

    Domainex appoints Hayley French as CEO to drive next phase of growth

    Contract research organisation Domainex has named Hayley French as its [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development

    START and OneOncology expand access to early phase cancer trials in US communities

    A new partnership will bring early phase clinical trials closer [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    PhaseV and Crohn’s & Colitis Foundation join forces to fast-track IBD clinical trials with AI

    A new collaboration aims to tackle the toughest challenges in [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development

    myTomorrows unveils new SaaS platform to streamline global expanded access programs

    Health tech company myTomorrows has launched a dedicated platform to [...]

    May 5, 2026
Previous737475Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • India’s CDMO market needs science, not just scale, says Lupin Manufacturing Solutions CEO
    Categories: Biotech & Pharma Business, Digital & Data, Drug Discovery & Development, Manufacturing & Supply Chain, Pharmaceuticals and therapeutics, Research & Development
  • Natus expands AI-powered EEG analysis across Europe
    Categories: Central Nervous System, Digital & Data, Medical devices
  • Enterome data link CD8 T-cell expansion to progression-free survival in lymphoma
    Categories: Advanced Therapies, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top